A well connected and effective infrastructure, a high density of research and development as well as close networking are of great value, not only to founders. Within the successful healthcare cluster Berlin-Brandenburg, these include numerous technology parks in the region. The parks offer optimal space including state of the art laboratories to start-up and grown-up companies.
SOTIO Biotech licenses ADCs from Lonza subsidiary Synaffix BV
Latest NewsSotio hsd licenced Synaffix’ ADC platform for up to US$740m to develop up to three next generation bioconjugates.
World Health Summit opened in Berlin
Latest NewsOn Sunday, the World Health Summit with more than 300 speakers officially kicked off in Berlin. The three day event focuses on climate change and health, pandemic prevention, and digital technologies.
Synerkine Pharma BV secures EUR 12.1m in Series A extension
Latest NewsDutch Synerkine Pharma BV has closed a Seris A extension financincg at €12.1m to accelerate clinical development of its pain killer SK-01.
AI helps classifying brain tumours during surgery
Latest NewsA method to quickly classify central nervous system (CNS) tumours, combining rapid sequencing and deep-learned AI models, may enable molecular diagnosis in less than 90 minutes, Dutch researchers report.
Test TSKgel UP-SW UHPLC SEC columns risk-free
ProductsTry TSKgel UP-SW columns for SEC analysis of biomolecules risk-free for 30 days
Infrastructure makes the difference
BackgroundA well connected and effective infrastructure, a high density of research and development as well as close networking are of great value, not only to founders. Within the successful healthcare cluster Berlin-Brandenburg, these include numerous technology parks in the region. The parks offer optimal space including state of the art laboratories to start-up and grown-up companies.
Gearing up on NANO: Pharmatech for nanodrugs
Sponsored PublicationsManufacturing of COVID vaccines showed that large-scale production of lipid nanoparticles (LNPs) as a delivery vehicle for mRNA vaccines is already possible. As nanocarrier-based formulations became mainstream, however, insufficiencies in existing technologies for routine GMP manufacturing became apparent. LEON is committed to bridging these technology gaps through its unique FR-JET technology and innovative manufacturing equipment.
Agomab Therapeutics NV raises US$100m in Series C financing
Latest NewsBelgian fibrosis specialist Agomab Therapeutics NV has raised US$100m to advance development of its pipeline.
Strengthening for start-up
AppointmentsThe Swedish start-up AAX Biotech welcomed Maria Lisa Knudsen as its new Managing Director at the end of September.
AstronauTx closes £48m Series A financing
Latest NewsAlzheimer’s specialist AstronauTx Ltd has closed a £48m Series A financing to create new treatments for Alzheimer’s diseas